See how your reported results read as versioned evidence records β linked to experiments and limitations.Know what the science actually supports before you trust the answer.
Press Enter β΅ to review claims
Explore by Goal
"The greatest challenge to any thinker is stating the problem in a way that will allow a solution."
- Bertrand Russell
Quick Explanation
Copied
Author Review (skeptical, data-grounded)
βThai Phamβ is ambiguous (multiple plausible homonyms in bibliographic indices). The provided record shows only 2 papers directly attributed to the author, and they appear non-bioinformatics / non-biomedical in the available metadataβso biological scientific strength cannot be robustly assessed from the current evidence.
Long Explanation
Author Review: Thai Pham
Date: March 25, 2026 β’ Evidence-based β’ Skeptical & critical β’ Inline-cited when external sources are used
Evidence sufficiency check (identity + scope)
Identity ambiguity: βThai Phamβ can refer to multiple different authors in public indexing. The provided OpenAlex matches include several distinct people with similar names (e.g., different ORCIDs and citation profiles), so homonym conflation is a major risk.
Current attributed works: the provided author record lists 2 papers attributed to T. Pham: (i) βSurface Plasmonic Resonance Sensor for Wider Range of Low Refractive Index Detectionβ and (ii) βDescription of cyclopropane with Backone equation of stateβ.
Domain mismatch (for bio/biomedical strength): based on the titles provided, the available evidence for this βThai Phamβ record looks primarily in sensing/physical chemistry rather than biology/genomics/bioinformatics. Therefore, the authorβs biological scientific strength is not well supported by the current record.
Publication & citation signal (from provided metrics)
Author record fields provided
Value
H-index
2
Total citations
9
Paper count
2
Listed affiliations
[] (none provided)
Listed papers
2 (titles provided)
Critical interpretation: low H-index and total citations are consistent with either (a) early-career / narrow publication footprint, (b) incomplete attribution/disambiguation, or (c) a discipline where citation practices differ. With only 2 papers attributed here, the citation metrics are fragile.
Visual evidence from the provided research datasets (method quality, effect sizes)
The following figures are generated from the provided extracted results and correspond to the cited papers (not automatically assumed to be by the βThai Phamβ author named above). They are included to show how rigorous the supplied studies are, and to highlight the kind of quantitative evidence the authorβs corpus may (or may not) contain.
1) HLA-B*58:01 prevalence across groups + SCAR association (meta-analysis)
Pooled HLA-B*58:01 prevalence is reported for (a) allopurinol-induced SCAR cases, (b) allopurinol-tolerant controls, and (c) general population controls; a pooled OR is also provided for association with SCARs.
Source: living systematic review & meta-analysis in Scientific Reports (2025)
Association magnitude (OR): pooled OR = 117.6 (95% CI 70.3β196.8) with I2 = 45%.
2) Steered MD: effect of protein backbone restraint mode on rupture force (example metric)
The provided extracted table contains Fmax_pN values across 6 proteinβligand systems for 6 restraint modes. To keep the visualization truthful without inventing aggregation rules, this plot shows the per-mode mean rupture force across the 6 PDB systems using only the provided values for each mode.
Source: simulations paper in Scientific Reports (2024)
Skeptical interpretation: rupture force is a non-equilibrium SMD observable and may not map directly to equilibrium residence time; the paper itself flags limits such as pulling velocity and limited systems.
3) Pertussis immunogenicity at 5 years after booster (antibody persistence)
The provided dataset includes GMCs for anti-PT IgG and long-term seroprotection rates (>20 IU/mL) at 5 years across groups.
Source: JAMA Network Open (2024)
Confounding / bias risks: the provided extraction indicates sponsor involvement (BioNet-Asia employment/grants) and immunogenicity endpoints (not direct clinical efficacy). That limits causal interpretation and external generalization.
Overall assessment of βThai Phamβ (based on provided attribution only)
What seems reasonably supported
The provided author record has very limited bibliographic footprint for the specific homonym βT. Phamβ (2 papers; h-index 2; total citations 9).
The authorβs research topics (from titles given) appear to be sensor/physical chemistry rather than the biomedical domains showcased by the supplied datasets (HLA pharmacogenomics, pertussis immunogenicity, influenza serodiagnostics, proteinβligand steered MD, etc.).
Major red flags / uncertainties
Homonym conflation risk is high: βThai Phamβ matches multiple OpenAlex entries with different ORCIDs and very different citation profiles (provided list shows both low and high citation/h-index possibilities). Without ORCID or unique affiliation verification, attribution quality is uncertain.
Scope limitation: the evidence provided does not establish that this author contributed to the biomedical/mechanistic work represented by the datasets. Therefore, scoring βbiological scientific strengthβ is underdetermined.
Citation-metric fragility: with 2 papers, any metric is unstable and can be dominated by one moderately cited publication.
What would change my conclusion
Disambiguation confirmation (ORCID + exact author matching) showing that the author is the same person as the biomedical datasetsβ papers.
Additional first/last-author publications in relevant biological domains, plus methodological details (e.g., protocol preregistration for reviews; robustness checks; reproducibility assets).
Practical next step inside BGPT
Because name ambiguity is the largest uncertainty, the most valuable action is to disambiguate the homonym and then re-run a paper-by-paper evidence audit.
Data-table init (if needed)
Feedback:
Updated: March 25, 2026
BGPT Author Review
Scientific Quality
30%
The provided attributed record for βT. Pham / Thai Phamβ contains only 2 papers with a very small citation footprint (h-index 2; total citations 9). Titles suggest non-biomedical domains, so biological scientific strength is not evidenced. The largest red flag is author-name ambiguity/homonym risk, which makes attribution and any downstream quality judgment unreliable without ORCID-level disambiguation.
Communication Quality
40%
No direct author writing (abstracts, methods, figures, or discussion text) was provided to assess clarity. Based solely on the limited metadata, communication quality is unknown; the only defensible rating is low-to-moderate uncertainty due to absence of evidence.
Author Novelty
30%
Novelty cannot be established from only two paper titles and very limited metadata. With no topic descriptions beyond titles, and without confirmed authorship identity, novelty scoring is necessarily low-confidence.
Scientific Rigor
30%
Rigor cannot be evaluated because the provided record does not include methods, experimental design, data availability, statistical analyses, or replication evidence for the authorβs two listed papers. With only titles and no full-text content, any rigor assessment would be speculative.
No bioinformatics code is directly applicable because the query is an author scientific-strength review rather than a sequence/omics analysis task.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
The strongest explanation for why biological strength appears unassessed is not low ability, but insufficient disambiguation and missing full-text evidence; therefore, βlow biological strengthβ as an inherent trait is premature.
Another weak explanation is that citation metrics fully reflect quality; with only 2 papers, citation-based inference is unreliable and can be dominated by indexing errors or outlier impacts.
Science Art
Science Movie
Make a narrated HD Science movie for this answer ($32 per minute)
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Analysis 
Hypothesis Graveyard
Discussion